Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: As pillars of the bridge between Chinese and Western medicine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 55, Issue 5, 2011, Pages 859-868

  Wang, Xijun ^a   Sun, Hui ^a   Zhang, Aihua ^a   Sun, Wenjun ^a   Wang, Ping ^a   Wang, Zhigang ^a  

^a HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Biomarkers; Metabolomics; Principal component analysis; Systems biology; Traditional Chinese medicine; Western medicine

Indexed keywords

CHINESE DRUG; GINSENG EXTRACT; PANAX NOTOGINSENG EXTRACT; QIYINLIANGXUZHENG; UNCLASSIFIED DRUG; XINXUEYUZUZHENG; YIN CHEN HAO TANG;

ACUPUNCTURE; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; CLINICAL PRACTICE; DRUG EFFICACY; ETHNOPHARMACOLOGY; EVIDENCE BASED PRACTICE; HEALING; HEALTH; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JAUNDICE; LIVER DISEASE; MASS SPECTROMETRY; METABOLOMICS; MIGRAINE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARTIAL LEAST SQUARES REGRESSION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STROKE; TINNITUS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; BIOLOGICAL MARKERS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHINA; DATA INTERPRETATION, STATISTICAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; WESTERN WORLD;

EID: 79956151568     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.01.042     Document Type: Review

References (97)

1. Zhang A., Sun H., Wang Z., Sun W., Wang P., Wang X. Metabolomics: towards understanding traditional Chinese medicine. Planta Med. 2010, 76:2026-2035.
2. Nicholson J.K. Global systems biology, personalized medicine and molecular epidemiology. Mol. Syst. Biol. 2008, 2:52-57.
3. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
4. Arakaki A.K., Skolnick J., McDonald J.F. Marker metabolites can be therapeutic targets as well. Nature 2008, 456:443.
5. Wang M., Lamers R.J., Korthout H.A., van Nesselrooij J.H., Witkamp R.F., van der Heijden R., Voshol P.J., Havekes L.M., Verpoorte R., van der Greef J. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother. Res. 2005, 19:173-182.
6. Oliver S.G., Winson M.K., Kell D.B., Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol. 1998, 16:373-378.
7. Nicholson J.K., Wilson I.D. Understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. 2003, 2:668-676.
8. Vineis P., Khan A.E., Vlaanderen J., Vermeulen R. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ. Health 2003, 8:54.
9. Workentine M.L., Harrison J.J., Weljie A.M., Tran V.A., Stenroos P.U., Tremaroli V., Vogel H.J., Ceri H., Turner R.J. Phenotypic and metabolic profiling of colony morphology variants evolved from Pseudomonas fluorescens biofilms. Environ. Microbiol. 2010, 12:1565-1577.
10. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
11. Hines A., Staff F.J., Widdows J., Compton R.M., Falciani F., Viant M.R. Discovery of metabolic signatures for predicting whole organism toxicology. Toxicol. Sci. 2010, 115:369-378.
12. Wang J., Reijmers T., Chen L., Van Der Heijden R., Wang M., Peng S., Hankemeier T., Xu G., Van Der Greef J. Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics. Metabolomics 2009, 5:407-418.
13. Pexa A., Boeger R.H., Henle T., Schwedhelm E., Deussen A. Effects of moderate hyperhomocysteinaemia induced by 4 weeks methionine-enriched diet on metabolite profile and mesenteric artery function in rats. Br. J. Nutr. 2009, 99:993-999.
14. Astle J., Ferguson J.T., German J.B., Harrigan G.G., Kelleher N.L., Kodadek T., Parks B.A., Roth M.J., Singletary K.W., Wenger C.D., Mahady G.B. Characterization of proteomic and metabolomic responses to dietary factors and supplements. J. Nutr. 2007, 137:2787-2793.
15. Lee R., West D., Phillips S.M., Britz-McKibbin P. Differential metabolomics for quantitative assessment of oxidative stress with strenuous exercise and nutritional intervention: thiol-specific regulation of cellular metabolism with N-acetyl-L-cysteine pretreatment. Anal. Chem. 2010, 82:2959-2968.
16. Urakami K., Zangiacomi V., Yamaguchi K., Kusuhara M. Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry. Biomed. Res. 2010, 31:161-163.
17. Tohge T., Fernie A.R. Combining genetic diversity, informatics and metabolomics to facilitate annotation of plant gene function. Nat. Protoc. 2010, 5:1210-1227.
18. Pluskal T., Nakamura T., Villar-Briones A., Yanagida M. Metabolic profiling of the fission yeast S. pombe: quantification of compounds under different temperatures and genetic perturbation. Mol. Biosyst. 2010, 6:182-198.
19. Clayton T.A., Lindon J.C., Cloarec O., Antti H., Charuel C., Hanton G., Provost J.P., Le Net J.L., Baker D., Walley R.J., Everett J.R., Nicholson J.K. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006, 440:1073-1077.
20. Nomura D.K., Dix M.M., Cravatt B.F. Activity-based protein profiling for biochemical pathway discovery in cancer. Nat. Rev. Cancer 2010, 10:630-638.
21. Rocha C.M., Barros A.S., Gil A.M., Goodfellow B.J., Humpfer E., Spraul M., Carreira I.M., Melo J.B., Bernardo J., Gomes A., Sousa V., Carvalho L., Duarte I.F. Metabolic profiling of human lung cancer tissue by 1H high resolution magic angle spinning (HRMAS) NMR spectroscopy. J. Proteome Res. 2010, 9:319-332.
22. Holmes E., Loo R.L., Stamler J., Bictash M., Yap I.K., Chan Q., Ebbels T., De Iorio M., Brown I.J., Veselkov K.A., Daviglus M.L., Kesteloot H., Ueshima H., Zhao L., Nicholson J.K., Elliott P. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453:396-401.
23. Cascante M., Benito A., Zanuy M., Vizán P., Marín S., de Atauri P. Metabolic network adaptations in cancer as targets for novel therapies. Biochem. Soc. Trans. 2010, 38:1302-1306.
24. Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., Laxman B., Mehra R., Lonigro R.J., Li Y., Nyati M.K., Ahsan A., Kalyana-Sundaram S., Han B., Cao X., Byun J., Omenn G.S., Ghosh D., Pennathur S., Alexander D.C., Berger A., Shuster J.R., Wei J.T., Varambally S., Beecher C., Chinnaiyan A.M. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.
25. Wang H., Ma C., Ma L., Du Z., Wang H., Ye H., Li G., Liu B., Xu G. Secondary metabolic profiling and artemisinin biosynthesis of two genotypes of Artemisia annua. Planta Med. 2009, 75:1625-1633.
26. Fukushima A., Kusano M., Nakamichi N., Kobayashi M., Hayashi N., Sakakibara H., Mizuno T., Saito K. Impact of clock-associated Arabidopsis pseudo-response regulators in metabolic coordination. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7251-7256.
27. Catchpole G.S., Beckmann M., Enot D.P., Mondhe M., Zywicki B., Taylor J., Hardy N., Smith A., King R.D., Kell D.B., Fiehn O., Draper J. Hierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato crops. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14458-14462.
28. Lanza I.R., Zhang S., Ward L.E., Karakelides H., Raftery D., Nair K.S. Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS ONE 2010, 5:10538.
29. Connor S.C., Hansen M.K., Corner A., Smith R.F., Ryan T.E. Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol. Biosyst. 2010, 6:909-921.
30. Jian W.X., Yuan Z.K., Huang X.P. Detection and analysis on plasma metabolomics in patient with coronary heart disease of Xin-blood stasis syndrome pattern. Zhongguo. Zhong. Xi. Yi. Jie. He. Za. Zhi. 2010, 30:579-584.
31. Lawaetz A.J., Schmidt B., Staerk D., Jaroszewski J.W., Bro R. Application of rotated PCA models to facilitate interpretation of metabolite profiles: commercial preparations of St. John's Wort. Planta Med. 2009, 75:271-279.
32. Kim H.K., Wilson E.G., Choi Y.H., Verpoorte R. Metabolomics: a tool for anticancer lead-finding from natural products. Planta Med. 2010, 76:1094-1102.
33. Mirnezhad M., Romero-González R.R., Leiss K.A., Choi Y.H., Verpoorte R., Klinkhamer P.G. Metabolomic analysis of host plant resistance to thrips in wild and cultivated tomatoes. Phytochem. Anal. 2010, 21:110-117.
34. López-Gresa M.P., Maltese F., Bellés J.M., Conejero V., Kim H.K., Choi Y.H., Verpoorte R. Metabolic response of tomato leaves upon different plant-pathogen interactions. Phytochem. Anal. 2010, 21:89-94.
35. Anderson P.E., Raymer M.L., Kelly B.J., Reo N.V., DelRaso N.J., Doom T.E. Characterization of H NMR spectroscopic data and the generation of synthetic validation sets. Bioinformatics 2009, 25:2992-3000.
36. Strassburg K., Walther D., Takahashi H., Kanaya S., Kopka J. Dynamic transcriptional and metabolic responses in yeast adapting to temperature stress. OMICS 2010, 14:249-259.
37. Xu F., Zou L., Ong C.N. Multiorigination of chromatographic peaks in derivatized GC/MS metabolomics: a confounder that influences metabolic pathway interpretation. J. Proteome Res. 2009, 8:5657-5665.
38. Shroff R., Rulísek L., Doubsky J., Svatos A. Acid-base-driven matrix-assisted mass spectrometry for targeted metabolomics. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10092-10096.
39. Nicholoson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. 2002, 1:153-161.
40. Want E.J., Wilson I.D., Gika H., Theodoridis G., Plumb R.S., Shockcor J., Holmes E., Nicholson J.K. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 2010, 5:1005-1018.
41. van der Greef J., van Wietmarschen H., Schroën J., Wang M., Hankemeier T., Xu G. Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine. Planta Med. 2010, 76:2036-2047.
42. Sheng Y., Wenxia Z., Yongxiang Z., Cunyu Y., Yimin Z. Effects of Liuwei Dihuang decoction on ion channels and synaptic transmission in cultured hippocampal neuron of rat. J. Ethnopharmacol. 2006, 106:166-172.
43. Wang P., Sun H., Lv H., Sun W., Yuan Y., Han Y., Wang D., Zhang A., Wang X. Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J. Pharm. Biomed. Anal. 2010, 53:631-645.
44. Lu X., Xiong Z., Li J., Zheng S., Huo T., Li F. Metabonomic study on 'Kidney-Yang Deficiency syndrome' and intervention effects of Rhizoma Drynariae extracts in rats using ultra performance liquid chromatography coupled with mass spectrometry. Talanta 2011, 83:700-708.
45. Ma T., Tan C., Zhang H., Wang M., Ding W., Li S. Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Mol. Biosyst. 2010, 6:613-619.
46. Wang M., Rang W., Zhang Q., Huo C., Ma Z., Wang Y., Yan X., Gao Y. NMR-spectroscopy-based metabonomic approach to analysis of Siwutang, a novel prescription, treated blood deficiency in mice. Zhongguo. Zhong. Yao. Za. Zhi. 2010, 35:630-634.
47. Xutian S., Zhang J., Louise W. New exploration and understanding of traditional Chinese medicine. Am. J. Chin. Med. 2009, 37:411-426.
48. Qiu Y., Chen M., Su M., Xie G., Li X., Zhou M., Zhao A., Jiang J., Jia W. Metabolic profiling reveals therapeutic effects of Herba Cistanches in an animal model of hydrocortisone-induced ; kidney-deficiency syndrome; Chin. Med. 2008, 3:3.
49. B. Yan, J. A, H. Hao, G. Wang, X. Zhu, W. Zha, L. Liu, E. Guan, Y. Zhang, S. Gu, Q, Huang, Y. Zheng, Metabonomic phenotype and identification of ; heart blood stasis obstruction pattern; and ; qi and yin deficiency pattern; of myocardial ischemia rat models, Sci. China C: Life Sci. 52 (2009) 1081-1090.
50. van Wietmarschen H., Yuan K., Lu C., Gao P., Wang J., Xiao C., Yan X., Wang M., Schroën J., Lu A., Xu G., van der Greef J. Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients. J. Clin. Rheumatol. 2009, 15:330-337.
51. Chen M., Zhao L., Jia W. Metabonomic study on the biochemical profiles of a hydrocortisone-induced animal model. J. Proteome Res. 2005, 4:2196-2391.
52. Luo H.G., Ding J., Yue G.X., Chen J.X. Metabonomic study of syndrome of liver qi stagnation and spleen deficiency in rats. Zhong. Xi. Yi. Jie. He. Xue. Bao. 2007, 5:307-313.
53. van der Greef J., Hankemeier T., McBurney R.N. Metabolomics-based systems biology and personalized medicine: moving towards n=1 clinical trials?. Pharmacogenomics 2006, 7:1087-1094.
54. Zhou X., Chen S., Liu B., Zhang R., Wang Y., Li P., Guo Y., Zhang H., Gao Z., Yan X. Development of traditional Chinese medicine clinical data warehouse for medical knowledge discovery and decision support. Artif. Intell. Med. 2010, 48:139-152.
55. Liang Z.H., Yin D.Z. Preventive treatment of traditional Chinese medicine as antistress and antiaging strategy. Rejuvenation Res. 2010, 13:248-252.
56. Winnike J.H., Li Z., Wright F.A., Macdonald J.M., O'Connell T.M., Watkins P.B. Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin. Pharmacol. Ther. 2010, 88:45-51.
57. Martin J.C., Canlet C., Delplanque B., Agnani G., Lairon D., Gottardi G., Bencharif K., Gripois D., Thaminy A., Paris A. 1H NMR metabonomics can differentiate the early atherogenic effect of dairy products in hyperlipidemic hamsters. Atherosclerosis 2009, 206:127-133.
58. Bast R.C. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare. Trans. Am. Clin. Climatol. Assoc. 2004, 115:233-247.
59. Manna S.K., Patterson A.D., Yang Q., Krausz K.W., Li H., Idle J.R., Fornace A.J., Gonzalez F.J. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J. Proteome Res. 2010, 9:4176-4188.
60. Li Z.Y., Zheng X.Y., Gao X.X., Zhou Y.Z., Sun H.F., Zhang L.Z., Guo X.Q., Du G.H., Qin X.M. Study of plasma metabolic profiling and biomarkers of chronic unpredictable mild stress rats based on gas chromatography/mass spectrometry. Rapid. Commun. Mass Spectrom. 2010, 24:3539-3546.
61. Kim Y.S., Maruvada P., Milner J.A. Metabolomics in biomarker discovery: future uses for cancer prevention. Future Oncol. 2008, 4:93-102.
62. Verpoorte R., Crommelin D., Danhof M., Gilissen L.J., Schuitmaker H., van der Greef J., Witkamp R.F. Commentary: ; A systems view on the future of medicine: inspiration from Chinese medicine?; J. Ethnopharmacol. 2009, 121:479-481.
63. Xu G., Ma X., Zhang Q., Li B., Huang L., Yu R., Liu H. Study of metabonomics on pharmacological action appraisal Rhizoma coptidis in rats. Zhongguo. Zhong. Yao. Za. Zhi. 2009, 34:1845-1847.
64. Agnolet S., Jaroszewski J.W., Verpoorte R., Staerk D. H NMR-based metabolomics combined with HPLC-PDA-MS-SPE-NMR for investigation of standardized Ginkgo biloba preparations. Metabolomics 2010, 6:292-302.
65. Zhang Q., Wang G.J., J.Y A., Wu D., Zhu L.L., Ma B., Du Y. Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats. Acta Pharmacol. Sin. 2009, 30:1674-1687.
66. Yan S., Wu B., Lin Z., Jin H., Huang J., Yang Y., Zhang X., Shen Z., Zhang W. Metabonomic characterization of aging and investigation on the anti-aging effects of total flavones of epimedium. Mol. Biosyst. 2009, 5:1204-1213.
67. Wu B., Yan S., Lin Z., Wang Q., Yang Y., Yang G., Shen Z., Zhang W. Metabonomic study on ageing: NMR-based investigation into rat urinary metabolites and the effect of the total flavone of epimedium. Mol. Biosyst. 2008, 4:855-861.
68. Xiao C., Dai H., Liu H., Wang Y., Tang H. Revealing the metabonomic variation of rosemary extracts using 1H NMR spectroscopy and multivariate data analysis. J. Agric. Food Chem. 2008, 56:10142-10153.
69. Xie G., Plumb R., Su M., Xu Z., Zhao A., Qiu M., Long X., Liu Z., Jia W. Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. J. Sep. Sci. 2008, 31:1015-1026.
70. Wang Y., Wang J., Yao M., Zhao X., Fritsche J., Schmitt-Kopplin P., Cai Z., Wan D., Lu X., Yang S., Gu J., Häring H.U., Schleicher E.D., Lehmann R., Xu G. Metabonomics study on the effects of the ginsenoside Rg3 in a beta-cyclodextrin-based formulation on tumor-bearing rats by a fully automatic hydrophilic interaction/reversed-phase column-switching HPLC-ESI-MS approach. Anal. Chem. 2008, 80:4680-4688.
71. Choi M.Y., Chai C., Park J.H., Lim J., Lee J., Kwon S.W. Effects of storage period and heat treatment on phenolic compound composition in dried Citrus peels (Chenpi) and discrimination of Chenpi with different storage periods through targeted metabolomic study using HPLC-DAD analysis. J. Pharm. Biomed. Anal. 2011, 54:638-645.
72. Liang Y.Z., Xie P.S., Chan K. Chromatographic fingerprinting and metabolomics for quality control of TCM. Comb. Chem. High Throughput Screen 2010, 13:943-953.
73. Chang W.T., Thissen U., Ehlert K.A., Koek M.M., Jellema R.H., Hankemeier T., van der Greef J., Wang M. Effects of growth conditions and processing on Rehmannia glutinosa using fingerprint strategy. Planta Med. 2006, 72:458-467.
74. Tianniam S., Bamba T., Fukusaki E. Pyrolysis GC-MS-based metabolite fingerprinting for quality evaluation of commercial Angelica acutiloba roots. J. Biosci. Bioeng. 2010, 109:89-93.
75. Sun B., Li L., Wu S., Zhang Q., Li H., Chen H., Li F., Dong F., Yan X. Metabolomic analysis of biofluids from rats treated with Aconitum alkaloids using nuclear magnetic resonance and gas chromatography/time-of-flight mass spectrometry. Anal. Biochem. 2009, 395:125-133.
76. Sun B., Li L., Wu S., Zhang Q., Li H., Chen H., Li F., Dong F., Yan X. A metabolomic analysis of the toxicity of Aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:1221-1228.
77. Li L., Sun B., Zhang Q., Fang J., Ma K., Li Y., Chen H., Dong F., Gao Y., Li F., Yan X. Metabonomic study on the toxicity of Hei-Shun-Pian, the processed lateral root of Aconitum carmichaelii Debx (Ranunculaceae). J. Ethnopharmacol. 2008, 116:561-568.
78. Law W.S., Huang P.Y., Ong E.S., Ong C.N., Li S.F., Pasikanti K.K., Chan E.C. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy. Rapid Commun. Mass Spectrom. 2008, 22:2436-2446.
79. Van Dorsten F.A., Daykin C.A., Mulder T.P., Van Duynhoven J.P. Metabonomics approach to determine metabolic differences between green tea and black tea consumption. J. Agric. Food Chem. 2006, 54:6929-6938.
80. Liu Y., Huang R., Liu L., Peng J., Xiao B., Yang J., Miao Z., Huang H. Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy. J. Pharm. Biomed. Anal. 2010, 52:136-141.
81. Ma C., Bi K., Zhang M., Su D., Fan X., Ji W., Wang C., Chen X. Metabonomic study of biochemical changes in the urine of Morning Glory Seed treated rat. J. Pharm. Biomed. Anal. 2010, 53:559-566.
82. Ma C., Bi K., Su D., Ji W., Zhang M., Fan X., Wang C., Chen X. Serum and kidney metabolic changes of rat nephrotoxicity induced by Morning Glory Seed. Food Chem. Toxicol. 2010, 48:2988-2993.
83. Wei L., Liao P., Wu H., Li X., Pei F., Li W., Wu Y. Toxicological effects of cinnabar in rats by NMR-based metabolic profiling of urine and serum. Toxicol. Appl. Pharmacol. 2008, 227:417-429.
84. Wang L., Zhou G.B., Liu P., Song J.H., Liang Y., Yan X.J., Xu F., Wang B.S., Mao J.H., Shen Z.X., Chen S.J., Chen Z. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4826-4831.
85. Zhang Q.Y., Mao J.H., Liu P., Huang Q.H., Lu J., Xie Y.Y., Weng L., Zhang Y., Chen Q., Chen S.J., Chen Z. A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3378-3383.
86. Park A.J. What's in a name? A systematic review of the nomenclature of Chinese medical formulae. J. Chin. Med. 2002, 30:419-427.
87. Wang X., Lv H., Sun H., Liu L., Yang B., Sun W., Wang P., Zhou D., Zhao L., Dou S., Zhang G., Cao H. Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2008, 48:1161-1168.
88. Xie B., Gong T., Gao R., Liu J., Zuo J., Wang X., Zhang Z. Development of rat urinary HPLC-UV profiling for metabonomic study on Liuwei Dihuang Pills. J. Pharm. Biomed. Anal. 2009, 49:492-497.
89. Zhao X., Zhang Y., Meng X., Yin P., Deng C., Chen J., Wang Z., Xu G. Effect of a traditional Chinese medicine preparation Xindi soft capsule on rat model of acute blood stasis: a urinary metabonomics study based on liquid chromatography-mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life. Sci. 2008, 873:151-158.
90. Lv Y., Liu X., Yan S., Liang X., Yang Y., Dai W., Zhang W. Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52:129-135.
91. Hu J., Wu Z.C., Wang J.J., Jiao Y. Comparison between modern and ancient thoughts about acupuncture treatment of migraine. Zhen. Ci. Yan. Jiu. 2009, 34:276-278.
92. Zhang T.S., Guan F., Jin C.N., Hao C.Y., Liu X.G., Ji L.X. Overview of relation between retaining time of acupuncture and effect for apoplexy. Zhen. Ci. Yan. Jiu. 2009, 34:140-142.
93. Wang K., Bugge J., Bugge S. A randomised, placebo-controlled trial of manual and electrical acupuncture for the treatment of tinnitus. Complement Ther. Med. 2010, 18:249-255.
94. Wan R.J., Li Y.H. Survey of acupuncture and moxibustion for clinical treatment of renal diseases. Zhongguo. Zhen. Jiu. 2009, 29:342-344.
95. Hao L., Zhao X.F., Li J. Approach to clinical trial design for acupuncture and moxibustion treatment of stroke. Zhongguo. Zhen. Jiu. 2009, 29:56-58.
96. Liang F., Koya D. Acupuncture: is it effective for treatment of insulin resistance?. Diabetes Obes. Metab. 2010, 12:555-569.
97. Wu Q., Zhang Q., Sun B., Yan X., Tang Y., Qiao X., Chen Q., Yu S., Liang F. (1)H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture. J. Pharm. Biomed. Anal. 2010, 51:698-704.